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Introduction
Despite the remarkable advances in septic shock (SSh)
management is still among the primary causes of death
worldwide and there have been no significant changes
in mortality over the last few decades.
Objectives
Taking into account the importance of early identifica-
tion and intervention in patients with SSh in relation to
prognosis, we studied few biomarkers, measured within
24 hours from the onset of SSh, along with clinical score
to compare their prognostic value for SSh and evaluate
their The purpose of the study was to ascertain the prog-
nostic value and evaluate their usefulness.
Methods
We conducted a prospective cohort study of 100 conse-
cutive critically-ill adult ICU patients on first-time
admission with SSh according to the Surviving Sepsis
Campaign during one year. Demographic data, severity
score (APACHEII and SOFA) and laboratory data were
recorded. The program used for the data processing and
statistical analysis was SPSS 15.0®
Results
Our study included 100 patients, 59% were men, the
respiratory tract (48%) and abdomen (24%) were the two
most common primary sites of infection. The median
length of ICU stay was 8 days; and the 28-day mortality
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Table 1. Distribution of biomarkers within 24 hours
Biomarker Overall population N = 100 Median
(IQR)
Survivors (n = 64) Median
(IQR)
Non-Survivors (n = 36) Median
(IQR)
P*
Age 64 (54.25-71) 63 (49-69) 66.5 (59-72.75) 0.04
APACHE II 26 (21.5-29.5) 25 (19-29) 27 (22.75-33) 0.002




1.71 (0.65-4.11) 1.06 (0.53-3.03) 2.84 (1.1-4.75) 0.002
PCT (ng/mL) 7.63 (1.48-24.04) 4.96 (1.07-23.31) 12.85 (4.23-35.52) ns
CRP (mg/L) 222.15 (131-337.9) 182.5 (131.62-96.24) 249.08 (124-349.55) ns
Lactate (mmol/L) 2.39 (1.68-3.96) 2.21 (1.62-3.38) 3.17 (1.96-4.56) 0.015
Platelets (x103/µL) 172.5 (106.5-276) 200(143.5-296) 125.65.2-202.5) 0.003
Cholesterol (mg/dL) 119.5 (81.5-153.5) 125.5 (91.75-161) 105 (67.75-135.75) ns
*Mann-Whitney test; IQR= interquartile range, MR-proADM = Mid-regional pro-adrenomedullin; PCT = Procalcitonin; CRP = C-reactive protein). MR-proADM
was the best predictor of 28-day mortality with the largest AUC (0.77; 95% CI: 0.7-0.89), followed by platelets (0.76; 95% CI: 0.67-0.85) and lactate (0.74; 95% CI:
0.64-0.83).
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rate was 36%. Non-survivors were older and had signifi-
cantly higher APACHE II and SOFA scores on ICU admis-
sion. The median MR-proADM and lactate levels were
significantly higher in 28 day- non-survivors, however the
number of platelets was significantly lower in this group.
Conclusions
The protein MR-proADM, lactate, platelets are strongly
associated with accurate assessment of the risk of mortal-
ity in SSh patients, and similar to the APACHE II and
SOFA score, when measured within the first 24 hours of
onset of SS.
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